Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) vs NewcelX Ltd. (NCEL)

Chemomab Therapeutics Ltd. Sponsored ADR and NewcelX Ltd. are both Biotechnology companies. Chemomab Therapeutics Ltd. Sponsored ADR and NewcelX Ltd. are of similar size ($16.0M and $15.6M). Across the 10 metrics below, Chemomab Therapeutics Ltd. Sponsored ADR leads on 5 and NewcelX Ltd. on 5.

Valuation

Metric CMMB NCEL Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 1.99 5.44 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (37.06%) (51.86%) (28.84%)
Free cash flow yield (210.63%) (36.48%) (23.03%)

Profitability

Metric CMMB NCEL Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (82.17%) 0.00% (57.72%)
Return on assets (70.70%) 0.00% (49.22%)
Return on invested capital (247.40%) 0.00% 0.00%

Growth

Metric CMMB NCEL Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 58.14% 11.18% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CMMB NCEL Biotechnology median
Debt to equity 0.00 0.06 0.00
Current ratio 6.41 0.40 4.73
Net debt to EBITDA 1.09 0.74 0.96

Dividend

Metric CMMB NCEL Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CMMB NCEL Biotechnology median
Market cap 15.95m 15.56m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack